undamentalytics Newsletter
Sign in

Lakeland Industries Inc (LAKE) stock

Add to watchlist

Add holding +

NASDAQ: LAKE Nasdaq Health Care Equipment Next results ~December 9, 2026

C Fundamentals grade

Lakeland Industries Inc is a US-listed company in the health care equipment industry. Its financial year ends in January.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$22

Revenue-to-maturity cash-flow model

Base case. Range ~$22–$28 across our lower- and higher-growth cases (0%–5% a year).

Price vs value

No Buy/Hold/Sell rating is issued: only 2 valuation models apply; a rating needs 3.

Lakeland Industries Inc valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders6 buying, 1 selling7 purchases and 1 sale by directors and officers, last 12 monthsInsider trades
  • Funds36 adding, 43 cuttingOf 11 active managers that changed their stake, 7 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Lakeland Industries files

Where Lakeland Industries stands after its latest 10-Q

Revenue for the twelve months to July 2026 was $191m, down 0.3% on a year earlier, against growth of 8.8% a quarter earlier. That puts it 50 of 58 for growth among the health care equipment companies we cover. Free-cash-flow margin rose to -0.3% from -12.7% a year earlier. Operating margin widened to -4.1% from -9.7%. The diluted share count is up 14.1% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 3 of our 6 financial-health checks. Our revenue-to-maturity cash-flow model value is $21.97 a share, against a share price of $9.04.

Source: 10-Q filed September 9, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~December 9, 2026 (estimated)

Lakeland Industries Inc's trailing-twelve-month revenue fell 0.3% year on year, with a free-cash-flow margin of -0.3%. Where it stands out: stock pay as % of revenue of 1.6% ranks 25 of 123 health care equipment companies we cover. Where it lags: gross margin of 32.6% ranks 105 of 123 health care equipment companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 97.3% while net income fell 24.3%: a 122pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Margins widening. Operating margin is up 5.5 points on a year ago.

Things to watch

  • Revenue shrinking. Revenue fell 0.3% over the last 12 months.
  • Growth slowing. The growth rate is 9.2 points lower than a quarter earlier.
  • Loss-making. Operating margin is -4.1%: costs exceed revenue.
  • Burning cash. Free cash flow was -0.3% of revenue over the last 12 months.
  • Share dilution. Diluted shares rose 14.1% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 73% and a beta of 0.9 against the S&P 500.

Latest results: FY2027 Q2

Filed September 9, 2026
Earnings per share
-$0.15 against an average estimate of -$0.06: missed by 157.7%
Revenue
$50m, down 4.5% on a year earlier
Share reaction
-16.2% in the first session after the results on September 9, 2026, against -1.1% for the S&P 500
Next report
December 9, 2026; average EPS estimate $0.05

Lakeland Industries' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+1.8%
  • 1 week-1.6%
  • 1 month-12.9%
  • This year+1.2%
  • 1 year-45.5%
  • 5 years-56.8%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$191M
Operating margin
-4.1%
Net margin
-14.0%
EPS (TTM, diluted)
$-2.73

Growth

Revenue growth
−0.3%
Change in growth rate
−9.2 pts
Share count change
+14.1%

Cash

Free cash flow (TTM)
-$668,000
FCF margin
-0.3%
Stock pay % of revenue
1.6%

Earnings

Last results
September 9, 2026
Next results (est.)
December 8, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Lakeland Industries Inc valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 2 valuation models apply; a rating needs 3.

Valuation models

We value Lakeland Industries Inc as an operating company, with every model that fits that kind of business. Cost of equity 9.9%: the 10-year Treasury yield (4.9%) plus a beta of 1.11 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$22 ~$22–$28 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$19 ~$22–$95 Included, half weight
Combined value Weighted average of the models that apply: the primary model (revenue-to-maturity model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$21 ~$19–$22 2 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Lakeland Industries Inc with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20162017201820192020202120222023202420252026Now
Share price$12.65$10.61$13.79$10.88$13.64$27.20$20.56$14.17$17.78$23.03$9.42$8.95
Market value$92m$78m$106m$89m$110m$221m$166m$110m$134m$171m$91m$88m
+ Net debt (− = net cash)−$7m−$10m−$16m−$13m−$15m−$53m−$53m−$25m−$25m−$17m−$13m$9m
Enterprise value$85m$67m$90m$76m$95m$169m$113m$85m$109m$154m$78m$97m
Multiples
Price / sales 0.9x0.9x1.1x0.9x1.0x1.4x1.4x1.0x1.1x1.0x0.5x0.5x
Price / earnings 23.8x20.0xn/m60.9x33.4x6.3x14.6x58.5x24.7x———
Price / free cash flow —7.0x——42.9x5.7x13.8x—15.2x———
EV / EBITDA 6.6x8.4x9.8x16.8x12.6x3.7x6.3x12.1x13.8x———

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

27 /100

Weak moat

How hard Lakeland Industries's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median 1.8% of total assets over 10 years.

  • Pricing power 11 / 20

    Gross margin has been a median 39.3%, moving by 4.5 percentage points (standard deviation) across 10 years.

  • Durability 1 / 20

    Operating margin has been a median 7.2%; its worst year was -9.7%.

  • Cash conversion 5 / 20

    Free cash flow was positive in 5 of 10 years, at a median -0.0% of revenue.

  • Discipline 10 / 20

    The diluted share count rose 20.6% over five years; stock-based pay has been a median 0.9% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: December 9, 2026, after the close. Analysts expect revenue of $50m and EPS of $0.05 (range $0.01 to $0.09) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$0.58 +43% $199m +4%
Next $0.54 +192% $216m +8%

Next year's EPS estimate has moved −7.0% in 90 days, across 2 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +329.6% on 90 days ago. In the last 30 days, 0 analysts raised Lakeland Industries Inc's forecast and 2 cut it.

Consensus EPS forecast Lakeland Industries Inc, last 90 days
−$1.00 −$0.50 $0.00 $0.50 $1.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.14 Current fiscal year, 60 days ago: −$0.14 Current fiscal year, 30 days ago: −$0.14 Current fiscal year, 7 days ago: −$0.14 Current fiscal year, Now: −$0.58 −$0.58 Next fiscal year, 90 days ago: $0.57 Next fiscal year, 60 days ago: $0.57 Next fiscal year, 30 days ago: $0.57 Next fiscal year, 7 days ago: $0.57 Next fiscal year, Now: $0.54 $0.54

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.14$0.57
60 days ago −$0.14$0.57
30 days ago −$0.14$0.57
7 days ago −$0.14$0.57
Now −$0.58$0.54

Earnings against estimates

Quarter toEstimateActualSurprise
Jul 2026 −$0.06 −$0.15 −157.7%
Apr 2026 −$0.14 −$0.03 +77.9%
Jan 2026 −$0.28 −$0.16 +43.5%
Oct 2025 $0.23 −$1.70 −853.6%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, September 9, 2026

No numeric guidance in Lakeland Industries Inc's latest earnings release (filed September 9, 2026). Some companies give their outlook only on the earnings call.

Analyst recommendations

4 analysts, Oct 2026
Buy4100%
Hold00%
Sell00%

Monthly trend

  1. Oct 2026134
  2. Sep 2026134

Counts of recommendations published by analysts covering Lakeland Industries Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
16.0%
of tradable shares
Days to cover
12.93
at average volume
Short interest, 1 month
+12%
to October 15, 2026
Held by institutions
83%
of shares
Held by insiders
13.2%
of shares
Employees
2,570
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −45.5%

$16.43 on October 31, 2025 to $8.95

ThenNowEffect
Revenue (last 12 months) $192m $191m −0.3%
P/S multiple 0.7x 0.5x −37.6%
Share count 9m 10m −12.3%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −38.1%

$14.45 on November 3, 2023 to $8.95

ThenNowEffect
Revenue (last 12 months) $119m $191m +60.3%
P/S multiple 0.9x 0.5x −50.3%
Share count 8m 10m −22.2%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
LAKE−20%−39%+41%+39%−65%+1%
Industry peers (median)−7%−37%−9%−20%−16%−15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
LAKE42%42%58%67%42%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
LAKE−58%−49%−32%−25%−70%−29%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 83% from February 9, 2021 to March 27, 2026. Getting back needed a 473% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$7.58 – $16.66
From 52-week high
−46.3%
vs 50-day average
−13.3%
vs 200-day average
−11.7%
Volatility (1 year)
73%
Beta vs S&P 500
0.92

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
4 up, 8 down
typical move ±12.6%
After a week
6 up, 6 down
typical move ±12.2%
After a month
7 up, 5 down
typical move ±15.4%
Results releasedNext dayS&P 500 next day5 days21 days
September 9, 2026 −16.2% −1.1% −9.6% −12.3%
June 9, 2026 +20.6% −1.9% +5.5% +17.2%
April 16, 2026 +19.5% +1.5% +8.3% +1.7%
December 9, 2025 −39.0% +0.6% −44.6% −40.9%
September 10, 2025 −1.4% +1.1% +0.8% +19.9%
June 9, 2025 −16.4% +0.7% −23.6% −20.8%
April 9, 2025 −4.8% +5.7% −4.0% +3.3%
December 6, 2024 −2.5% −0.3% +0.4% +11.3%
September 4, 2024 −7.8% −0.4% −17.7% −19.0%
June 5, 2024 +17.0% +1.2% +18.4% +19.0%
April 11, 2024 −4.9% −0.6% −7.1% −1.1%
December 7, 2023 +1.4% +1.2% +5.9% +18.2%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Lakeland Industries Inc in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Lakeland Industries Inc
$120M $140M $160M $180M $200M FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 Revenue (TTM), FY24 Q3: $122.4M Revenue (TTM), FY24 Q4: $124.7M Revenue (TTM), FY25 Q1: $132.3M Revenue (TTM), FY25 Q2: $137.7M Revenue (TTM), FY25 Q3: $151.8M Revenue (TTM), FY25 Q4: $167.2M Revenue (TTM), FY26 Q1: $177.6M Revenue (TTM), FY26 Q2: $191.6M Revenue (TTM), FY26 Q3: $193.5M Revenue (TTM), FY26 Q4: $192.6M Revenue (TTM), FY27 Q1: $193.3M Revenue (TTM), FY27 Q2: $191M $191M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY24 Q3 $122.4M
FY24 Q4 $124.7M
FY25 Q1 $132.3M
FY25 Q2 $137.7M
FY25 Q3 $151.8M
FY25 Q4 $167.2M
FY26 Q1 $177.6M
FY26 Q2 $191.6M
FY26 Q3 $193.5M
FY26 Q4 $192.6M
FY27 Q1 $193.3M
FY27 Q2 $191M
Revenue growth, TTM YoY Lakeland Industries Inc
-10% 0% 10% 20% 30% 40% FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 Revenue growth, TTM YoY, FY24 Q3: 10.7% Revenue growth, TTM YoY, FY24 Q4: 10.5% Revenue growth, TTM YoY, FY25 Q1: 15.8% Revenue growth, TTM YoY, FY25 Q2: 15.6% Revenue growth, TTM YoY, FY25 Q3: 24.0% Revenue growth, TTM YoY, FY25 Q4: 34.1% Revenue growth, TTM YoY, FY26 Q1: 34.3% Revenue growth, TTM YoY, FY26 Q2: 39.1% Revenue growth, TTM YoY, FY26 Q3: 27.4% Revenue growth, TTM YoY, FY26 Q4: 15.2% Revenue growth, TTM YoY, FY27 Q1: 8.8% Revenue growth, TTM YoY, FY27 Q2: -0.3% -0.3%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY24 Q3 10.7%
FY24 Q4 10.5%
FY25 Q1 15.8%
FY25 Q2 15.6%
FY25 Q3 24.0%
FY25 Q4 34.1%
FY26 Q1 34.3%
FY26 Q2 39.1%
FY26 Q3 27.4%
FY26 Q4 15.2%
FY27 Q1 8.8%
FY27 Q2 -0.3%
Operating margin (TTM) Lakeland Industries Inc
-15% -10% -5% 0% 5% 10% FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 Operating margin (TTM), FY24 Q3: 7.6% Operating margin (TTM), FY24 Q4: 4.8% Operating margin (TTM), FY25 Q1: 4.7% Operating margin (TTM), FY25 Q2: 0.7% Operating margin (TTM), FY25 Q3: -1.2% Operating margin (TTM), FY25 Q4: -5.5% Operating margin (TTM), FY26 Q1: -9.1% Operating margin (TTM), FY26 Q2: -9.7% Operating margin (TTM), FY26 Q3: -10.8% Operating margin (TTM), FY26 Q4: -8.1% Operating margin (TTM), FY27 Q1: -4.4% Operating margin (TTM), FY27 Q2: -4.1% -4.1%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY24 Q3 7.6%
FY24 Q4 4.8%
FY25 Q1 4.7%
FY25 Q2 0.7%
FY25 Q3 -1.2%
FY25 Q4 -5.5%
FY26 Q1 -9.1%
FY26 Q2 -9.7%
FY26 Q3 -10.8%
FY26 Q4 -8.1%
FY27 Q1 -4.4%
FY27 Q2 -4.1%
FCF margin (TTM) Lakeland Industries Inc
-20% -10% 0% 10% FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 FCF margin (TTM), FY24 Q3: 4.3% FCF margin (TTM), FY24 Q4: 7.1% FCF margin (TTM), FY25 Q1: 4.3% FCF margin (TTM), FY25 Q2: 0.8% FCF margin (TTM), FY25 Q3: -7.5% FCF margin (TTM), FY25 Q4: -10.4% FCF margin (TTM), FY26 Q1: -13.1% FCF margin (TTM), FY26 Q2: -12.7% FCF margin (TTM), FY26 Q3: -11.3% FCF margin (TTM), FY26 Q4: -8.5% FCF margin (TTM), FY27 Q1: -3.1% FCF margin (TTM), FY27 Q2: -0.3% -0.3%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY24 Q3 4.3%
FY24 Q4 7.1%
FY25 Q1 4.3%
FY25 Q2 0.8%
FY25 Q3 -7.5%
FY25 Q4 -10.4%
FY26 Q1 -13.1%
FY26 Q2 -12.7%
FY26 Q3 -11.3%
FY26 Q4 -8.5%
FY27 Q1 -3.1%
FY27 Q2 -0.3%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2011 Jan 2011 2012 Jan 2012 2013 Jan 2013 2014 Jan 2014 2015 Jan 2015 2016 Jan 2016 2017 Jan 2017 2018 Jan 2018 2019 Jan 2019 2020 Jan 2020 2021 Jan 2021 2022 Jan 2022 2023 Jan 2023 2024 Jan 2024 2025 Jan 2025 2026 Jan 2026 LTM Jul 2026
Income
Revenue 100 96 95 91 93 100 86 96 99 108 159 118 113 125 167 193 191
Gross profit 30 29 27 25 32 36 32 36 34 38 79 51 46 51 69 63 62
EBITDA 6 4 1 1 8 13 8 9 5 8 46 18 7 8 −7 −13 −5
Operating income 4 2 −1 −0 7 12 7 8 4 6 44 16 6 6 −9 −16 −8
Net income 1 −0 −26 −0 8 4 4 0 1 3 35 11 2 5 −18 −25 −27
Diluted EPS $0.18 −$0.07 −$4.97 −$0.02 $1.33 $0.53 $0.53 $0.06 $0.18 $0.41 $4.34 $1.41 $0.24 $0.72 −$2.43 −$2.63 −$2.73
Growth (year on year)
Revenue — −3.2% −1.3% −3.9% +2.2% +6.7% −13.5% +11.4% +3.2% +8.9% +47.5% −25.5% −4.7% +10.5% +34.1% +15.2% −0.3%
EBITDA — −39.6% −85.9% — — +58.6% −37.2% +15.1% −51.0% +66.0% +509.6% −60.9% −60.7% +12.0% −184.4% — —
Operating income — −57.7% — — — +69.7% −42.0% +23.8% −57.9% +64.8% +646.9% −63.4% −65.5% +8.2% −254.6% — —
Net income — — — — — −54.1% +1.0% −88.7% — — +976.8% −67.8% −83.5% — −433.2% — —
Diluted EPS — — — — — −60.2% 0.0% −88.7% — — +958.5% −67.5% −83.0% — −437.5% — —
Margins
Gross margin 30.2% 29.9% 28.7% 27.2% 33.9% 36.5% 36.7% 37.7% 34.2% 35.2% 49.9% 43.0% 40.6% 41.1% 41.1% 32.9% 32.6%
EBITDA margin 6.1% 3.8% 0.5% 1.4% 8.6% 12.8% 9.3% 9.6% 4.6% 7.0% 28.8% 15.1% 6.2% 6.3% −4.0% −6.6% −2.5%
Operating margin 4.1% 1.8% −1.1% −0.4% 7.5% 11.9% 7.9% 8.8% 3.6% 5.5% 27.6% 13.6% 4.9% 4.8% −5.5% −8.1% −4.1%
Net margin 1.0% −0.4% −27.6% −0.1% 9.0% 3.9% 4.5% 0.5% 1.5% 3.0% 22.2% 9.6% 1.7% 4.4% −10.8% −13.1% −14.0%
Free-cash-flow margin −2.7% −5.1% 0.0% −5.2% 2.6% −1.4% 12.9% −0.3% −1.3% 2.4% 24.5% 10.1% −6.6% 7.1% −10.4% −8.5% −0.3%
Cash flow
Cash from operations −1 −0 1 −4 3 −1 11 1 2 4 41 13 −5 11 −16 −16 −1
Capital spending 2 5 1 1 1 1 0 1 3 1 2 1 2 2 2 1 −0
Free cash flow −3 −5 0 −5 2 −1 11 −0 −1 3 39 12 −7 9 −17 −16 −1
Stock-based pay — 1 0 0 1 1 0 0 1 −0 2 2 1 1 2 3 3
Free cash flow after stock pay — −5 −0 −5 1 −2 11 −1 −2 3 37 10 −9 7 −19 −20 −4
Balance sheet
Cash 6 6 7 5 7 7 10 16 13 15 53 53 25 25 17 13 18
Total debt — — — — — — — — — — — — — — — — 27
Net debt (negative = net cash) −6 −6 −7 −5 −7 −7 −10 −16 −13 −15 −53 −53 −25 −25 −17 −13 9
Diluted shares 6m 5m 5m 6m 6m 7m 7m 8m 8m 8m 8m 8m 8m 8m 7m 10m 10m
Returned to shareholders
Dividends — — — — — — — — — — — — — 1 1 1 3
Buybacks 2 0 0 — — — — 0 1 1 0 9 5 0 — — —
Total returned 2 0 0 — — — — 0 1 1 0 9 5 1 1 1 3

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

3 of 6 checks passed · July 31, 2026
What it owns · $207m
Short-term assets $137mLonger-term assets $70m
What it owes, and who funded it · $207m
Short-term liabilities $46mLonger-term liabilities $36mShareholders' equity $125m
  • Short-term assets cover short-term liabilities $137m of assets due within a year against $46m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $137m short-term assets against $36m of longer-dated liabilities.
  • More cash than debt $18m of cash against $29m of debt.
  • Debt below 40% of shareholders' equity Debt is 23% of equity.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$693,000 of operating cash flow against $29m of debt.
  • Operating profit covers interest at least five times over Operating income of −$8m against $2m of interest.

From Lakeland Industries Inc's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$3.1M
Diluted share count
+14.1%
year over year
Total shareholder yield
3.5%
dividends 3.5% + buybacks 0.0% of market value
Days sales outstanding
61 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care equipment
Last 12 months unless stated LAKE TMCI SIBN STIM ESTA CERS Median
Revenue, last 12 months $191m $205m $214m $155m $246m $254m $99m
Revenue growth, last 12 months −0.3% −4.0% 15.3% 39.6% 38.6% 74.6% 9.2%
Revenue growth, 3-year average 17.0% 7.1% 19.7% 31.7% 11.5% 89.8% 13.5%
Revenue growth, latest quarter −4.5% −4.2% 15.2% 9.1% 31.7% 9.5% 10.2%
Gross margin 32.6% 79.5% 79.5% 49.1% 70.5% 58.4% 61.2%
Operating margin −4.1% −26.2% −8.3% −14.7% −7.6% −1.0% −8.5%
Operating margin, 3-year average −4.4% −27.1% −17.9% −29.7% −27.9% −68.4% −17.9%
Net margin −14.0% −29.0% −6.9% −19.6% −15.8% −2.9% −12.0%
Cash from operations / revenue −0.4% −7.1% 1.2% −6.7% −13.1% 1.4% −1.9%
Free-cash-flow margin −0.3% −12.2% −2.1% −7.3% −16.9% 0.2% −3.9%
Free-cash-flow margin, 3-year average −4.1% −15.6% −8.7% −25.7% −36.3% −54.4% −7.0%
Stock pay / revenue 1.6% 14.6% 11.3% 3.8% 4.9% 8.4% 6.1%
Change in share count 14.1% 2.7% 3.8% 43.0% 4.2% 4.3% 4.0%

Median of all 134 companies we cover in health care equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

134 health care equipment companies
Measure Company Peer median Rank
Revenue growth Growth -0.3% 9.1% 103 of 129
Change in growth rate Growth -9.2pp -0.6pp 108 of 129
Gross margin Profitability 32.6% 61.9% 105 of 123
Operating margin Profitability -4.1% -8.3% 55 of 132
Net margin Profitability -14.0% -12.0% 71 of 133
Free-cash-flow margin Cash generation -0.3% -3.4% 53 of 128
Stock pay as % of revenue Cash generation 1.6% 6.1% 25 of 123
Long-term debt as % of assets Balance sheet 13.0% 24.2% 28 of 87
Change in share count Balance sheet 14.1% 3.3% 89 of 115
Days sales outstanding Balance sheet 61 days 57 days 72 of 118

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$69.6M
Institutions reporting
66
Shares held vs prior quarter
▼ 6.9%
Positions opened / closed
19 / 20

Top buyers and sellers, Q2 2026: 36 institutions bought and 43 sold ; the biggest buyer was Marshall Wace, LLP (+235K shares) and the biggest seller Blackrock, Inc (−398K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Royce & Associates LP $14.1M 1.3M 20.3% ▲ 8.7%
Private Capital Management, LLC $13.4M 1.2M 19.2% ▼ 17.2%
Pacific Ridge Capital Partners, LLC $10.4M 976K 15.0% ▲ 5.0%
Vanguard Capital Management LLC $4.2M 393K 6.0% ▲ 0.5%
Dimensional Fund Advisors LP $3.4M 320K 4.9% ▼ 2.7%
Morgan Stanley $2.9M 268K 4.1% ▼ 0.2%
Marshall Wace, LLP $2.5M 235K 3.6% New
Peapod Lane Capital LLC $2.2M 208K 3.2% ▲ 62.1%
Renaissance Technologies LLC $2M 183K 2.8% ▼ 8.8%
Blackrock, Inc. $1.7M 158K 2.4% ▼ 71.6%
Geode Capital Management, LLC $1.3M 122K 1.9% ▼ 46.3%
Millennium Management LLC $1.1M 107K 1.6% New

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Lakeland Industries Inc's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $72,803 7 trades by 6 insiders, last 12 months Insider sales History → $71,484 1 trade by 1 insider · 0% under pre-set plans
Net ▲ $1,319 net buying
Insider Date Trade Shares Price Value
Stokes Cameron See Remarks January 13, 2026 Buy 450 $9.43 $4,244
Swinea James Calven Jr. Interim CFO January 9, 2026 Buy 1,000 $8.71 $8,710
Hui An Chief Operating Officer January 9, 2026 Buy 2,000 $8.97 $17,940
Jenkins James M. President, CEO & Exec. Chair January 5, 2026 Buy 1,127 $8.88 $10,003
Phillips Barry G Chief Revenue Officer - Fire December 23, 2025 Buy 1,250 $8.71 $10,888
Yartz Laurel A. Chief Human Resources Officer December 22, 2025 Buy 1,350 $8.15 $11,000
Jenkins James M. President, CEO & Exec. Chair December 19, 2025 Buy 1,265 $7.92 $10,019
Shannon Roger D Chief Financial Officer December 16, 2025 Sell 8,869 $8.06 $71,484

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around December 8, 2026 estimated from the company's past filing pattern, not announced

  • September 9, 2026
  • June 9, 2026
  • April 16, 2026
  • December 9, 2025
  • September 10, 2025
  • June 9, 2025

Recent SEC filings

Data status

When each part of this page on Lakeland Industries Inc was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Lakeland Industries Inc in brief

What does Lakeland Industries Inc do?
Lakeland Industries Inc is a US-listed company in the health care equipment industry. Its financial year ends in January.
What is Lakeland Industries Inc's stock ticker?
Lakeland Industries Inc trades under the ticker LAKE on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Lakeland Industries Inc's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Lakeland Industries Inc reported revenue of $191M, 0.3% lower than a year earlier, according to its SEC filings.
What is Lakeland Industries Inc's free cash flow?
Lakeland Industries Inc's free-cash-flow margin is -0.3% of revenue over the trailing twelve months, ranking 53 of the 128 health care equipment companies we cover.
Who are Lakeland Industries Inc's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Royce & Associates LP, Private Capital Management, LLC and Pacific Ridge Capital Partners, LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Lakeland Industries Inc's market cap?
On November 2, 2026, Lakeland Industries Inc's market capitalisation was about $87.6M and net debt of $9M. Market figures come from third-party market data and may be delayed.
Does Lakeland Industries Inc pay a dividend?
Yes: Lakeland Industries Inc paid $3.1M in dividends over the trailing twelve months, a dividend yield of 3.47%.
How much debt does Lakeland Industries Inc have?
Lakeland Industries Inc's debt-to-equity ratio is 22.9%, from its latest balance sheet. The financial health section below sets out its other solvency checks.
Who are Lakeland Industries Inc's competitors?
In our Health Care Equipment peer group, the companies closest to Lakeland Industries Inc are Treace Medical Concepts, Inc., Si-bone, Inc., Neuronetics, Inc., Establishment Labs Holdings Inc. and Cerus Corp. The side-by-side comparison below sets their revenue, margins and growth against Lakeland Industries Inc's.
Are insiders buying or selling Lakeland Industries Inc stock?
Over the last 12 months, Lakeland Industries Inc's directors and officers reported 7 open-market purchases and 1 sales on Form 4. The insider trading page charts every trade.
When is Lakeland Industries Inc's next earnings date?
Around December 9, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Lakeland Industries Inc announces its own schedule.